Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DXR vs TFX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DXR
Daxor Corporation

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$59M
5Y Perf.-23.9%
TFX
Teleflex Incorporated

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$5.45B
5Y Perf.-66.0%

DXR vs TFX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DXR logoDXR
TFX logoTFX
IndustryMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$59M$5.45B
Revenue (TTM)$868K$2.96B
Net Income (TTM)$3M$-906M
Gross Margin91.4%53.3%
Operating Margin5.4%9.7%
Forward P/E92.2x18.3x
Total Debt$730K$2.73B
Cash & Equiv.$393M

DXR vs TFXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DXR
TFX
StockMay 20May 26Return
Daxor Corporation (DXR)10076.1-23.9%
Teleflex Incorporat… (TFX)10034.0-66.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: DXR vs TFX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DXR leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Teleflex Incorporated is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
DXR
Daxor Corporation
The Income Pick

DXR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.33
  • 27.9% 10Y total return vs TFX's -15.1%
  • Lower volatility, beta 0.33, Low D/E 2.0%, current ratio 0.17x
Best for: income & stability and long-term compounding
TFX
Teleflex Incorporated
The Growth Play

TFX is the clearest fit if your priority is growth exposure.

  • Rev growth -34.6%, EPS growth -14.7%, 3Y rev CAGR -10.6%
  • -34.6% revenue growth vs DXR's -93.8%
  • Lower P/E (18.3x vs 92.2x)
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthTFX logoTFX-34.6% revenue growth vs DXR's -93.8%
ValueTFX logoTFXLower P/E (18.3x vs 92.2x)
Quality / MarginsDXR logoDXR401.5% margin vs TFX's -30.6%
Stability / SafetyDXR logoDXRBeta 0.33 vs TFX's 1.06, lower leverage
DividendsTFX logoTFX1.1% yield; the other pay no meaningful dividend
Momentum (1Y)DXR logoDXR+33.8% vs TFX's +3.3%
Efficiency (ROA)DXR logoDXR9.8% ROA vs TFX's -12.3%, ROIC 1.3% vs 3.4%

DXR vs TFX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DXRDaxor Corporation

Segment breakdown not available.

TFXTeleflex Incorporated
FY 2025
Vascular Access
46.1%$918M
Interventional
32.5%$648M
Surgical
21.0%$418M
Other
0.5%$9M

DXR vs TFX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDXRLAGGINGTFX

Income & Cash Flow (Last 12 Months)

DXR leads this category, winning 4 of 6 comparable metrics.

TFX is the larger business by revenue, generating $3.0B annually — 3414.8x DXR's $867,859. DXR is the more profitable business, keeping 4.0% of every revenue dollar as net income compared to TFX's -30.6%. On growth, TFX holds the edge at -28.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
RevenueTrailing 12 months$867,859$3.0B
EBITDAEarnings before interest/tax$7M$478M
Net IncomeAfter-tax profit$3M-$906M
Free Cash FlowCash after capex-$5M$245M
Gross MarginGross profit ÷ Revenue+91.4%+53.3%
Operating MarginEBIT ÷ Revenue+5.4%+9.7%
Net MarginNet income ÷ Revenue+4.0%-30.6%
FCF MarginFCF ÷ Revenue-5.4%+8.3%
Rev. Growth (YoY)Latest quarter vs prior year-74.4%-28.5%
EPS Growth (YoY)Latest quarter vs prior year+78.2%-4.5%
DXR leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

TFX leads this category, winning 4 of 5 comparable metrics.

On an enterprise value basis, TFX's 18.0x EV/EBITDA is more attractive than DXR's 29.1x.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
Market CapShares × price$59M$5.5B
Enterprise ValueMkt cap + debt − cash$60M$7.8B
Trailing P/EPrice ÷ TTM EPS92.18x-6.09x
Forward P/EPrice ÷ next-FY EPS est.18.34x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple29.06x17.96x
Price / SalesMarket cap ÷ Revenue27.73x2.74x
Price / BookPrice ÷ Book value/share1.37x1.76x
Price / FCFMarket cap ÷ FCF2299.86x22.22x
TFX leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

DXR leads this category, winning 5 of 8 comparable metrics.

DXR delivers a 10.1% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-24 for TFX. DXR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to TFX's 0.87x.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
ROE (TTM)Return on equity+10.1%-23.7%
ROA (TTM)Return on assets+9.8%-12.3%
ROICReturn on invested capital+1.3%+3.4%
ROCEReturn on capital employed+1.7%+4.0%
Piotroski ScoreFundamental quality 0–955
Debt / EquityFinancial leverage0.02x0.87x
Net DebtTotal debt minus cash$729,966$2.3B
Cash & Equiv.Liquid assets$393M
Total DebtShort + long-term debt$729,966$2.7B
Interest CoverageEBIT ÷ Interest expense-6.11x-0.95x
DXR leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

DXR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in DXR five years ago would be worth $10,769 today (with dividends reinvested), compared to $3,191 for TFX. Over the past 12 months, DXR leads with a +33.8% total return vs TFX's +3.3%. The 3-year compound annual growth rate (CAGR) favors DXR at -4.8% vs TFX's -21.1% — a key indicator of consistent wealth creation.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
YTD ReturnYear-to-date-29.4%+1.0%
1-Year ReturnPast 12 months+33.8%+3.3%
3-Year ReturnCumulative with dividends-13.7%-50.9%
5-Year ReturnCumulative with dividends+7.7%-68.1%
10-Year ReturnCumulative with dividends+27.9%-15.1%
CAGR (3Y)Annualised 3-year return-4.8%-21.1%
DXR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DXR and TFX each lead in 1 of 2 comparable metrics.

DXR is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than TFX's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TFX currently trades 88.3% from its 52-week high vs DXR's 68.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
Beta (5Y)Sensitivity to S&P 5000.33x1.06x
52-Week HighHighest price in past year$14.76$139.63
52-Week LowLowest price in past year$7.10$100.18
% of 52W HighCurrent price vs 52-week peak+68.7%+88.3%
RSI (14)Momentum oscillator 0–10055.644.9
Avg Volume (50D)Average daily shares traded11K875K
Evenly matched — DXR and TFX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

TFX is the only dividend payer here at 1.09% yield — a key consideration for income-focused portfolios.

MetricDXR logoDXRDaxor CorporationTFX logoTFXTeleflex Incorpor…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$132.20
# AnalystsCovering analysts29
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS$1.35
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.5%
Insufficient data to determine a leader in this category.
Key Takeaway

DXR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TFX leads in 1 (Valuation Metrics). 1 tied.

Best OverallDaxor Corporation (DXR)Leads 3 of 6 categories
Loading custom metrics...

DXR vs TFX: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is DXR or TFX a better buy right now?

For growth investors, Teleflex Incorporated (TFX) is the stronger pick with -34.

6% revenue growth year-over-year, versus -93. 8% for Daxor Corporation (DXR). Daxor Corporation (DXR) offers the better valuation at 92. 2x trailing P/E, making it the more compelling value choice. Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — DXR or TFX?

Over the past 5 years, Daxor Corporation (DXR) delivered a total return of +7.

7%, compared to -68. 1% for Teleflex Incorporated (TFX). Over 10 years, the gap is even starker: DXR returned +27. 9% versus TFX's -15. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — DXR or TFX?

By beta (market sensitivity over 5 years), Daxor Corporation (DXR) is the lower-risk stock at 0.

33β versus Teleflex Incorporated's 1. 06β — meaning TFX is approximately 222% more volatile than DXR relative to the S&P 500. On balance sheet safety, Daxor Corporation (DXR) carries a lower debt/equity ratio of 2% versus 87% for Teleflex Incorporated — giving it more financial flexibility in a downturn.

04

Which is growing faster — DXR or TFX?

By revenue growth (latest reported year), Teleflex Incorporated (TFX) is pulling ahead at -34.

6% versus -93. 8% for Daxor Corporation (DXR). On earnings-per-share growth, the picture is similar: Daxor Corporation grew EPS 81. 5% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — DXR or TFX?

Daxor Corporation (DXR) is the more profitable company, earning 25.

2% net margin versus -45. 4% for Teleflex Incorporated — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXR leads at 29. 2% versus 12. 8% for TFX. At the gross margin level — before operating expenses — DXR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — DXR or TFX?

In this comparison, TFX (1.

1% yield) pays a dividend. DXR does not pay a meaningful dividend and should not be held primarily for income.

07

Is DXR or TFX better for a retirement portfolio?

For long-horizon retirement investors, Daxor Corporation (DXR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

33)). Both have compounded well over 10 years (DXR: +27. 9%, TFX: -15. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between DXR and TFX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

TFX pays a dividend while DXR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DXR

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 240%
Run This Screen
Stocks Like

TFX

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 31%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DXR and TFX on the metrics below

Revenue Growth>
%
(DXR: -74.4% · TFX: -28.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.